Skip to main content

Advertisement

Log in

High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Maertens JA, Raad II, Marr KA, Patterson TF Kontoyiannis DP, Cornely O, Bow EJ, Rahay G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Sellesiang D, Shoham S, Thompson GR LM 3rd, Maher RM, Schmitt-Hoffmann AH, Ullmann AJ ZB (2016) Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomized controlled, non inferiority trial. Lancet 387:760–769

    Article  PubMed  CAS  Google Scholar 

  2. Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, MjGT V, VITAL and Fungi Scope Mucormycosis Invesigators (2016) Isavuconazole treatment for mucormycosis: a singlearm open-label trial and case-control analysis. Lancet Infect Dis 16:828–837

    Article  PubMed  CAS  Google Scholar 

  3. Pettit NN, Carver PL (2015 Jul) Isavuconazole: a new option for the management of invasive fungal infections. Ann Pharmacother 49(7):825–842

    Article  PubMed  CAS  Google Scholar 

  4. Dutch Working Party on Antibiotic Policy. SWAB Guidelines for the Management of Invasive Fungal Infections. Revised version. Released: 14 December 2017. Available at http://www.swab.nl/swab/cms3.nsf/uploads/3AA7A56CE879587BC12581F80061297F/$FILE/SWAB%20Richtlijn%20Mycosen%202017%20(final).pdf (last access, January 31, 2018)

  5. Wilby KJ. A review of the clinical pharmacokinetics and pharmacodynamics of isavuconazole. Eur J Drug Metab Pharmacokinet 2017 [Epub ahead of print]

Download references

Funding

This work was supported by internal funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena Arsiè.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

ESM 1

(DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arsiè, E., Piconi, S., Iavarone, M. et al. High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis. Eur J Clin Pharmacol 74, 1089–1090 (2018). https://doi.org/10.1007/s00228-018-2462-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-2462-0

Navigation